Anebulo Pharmaceuticals Inc
General ticker "ANEB" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $36.0M
Anebulo Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -36.2%.
Estimated limits based on current volatility of 15.7%: low 0.94$, high 1.28$
Factors to consider:
- Current price 15.6% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [1.48$, 3.34$]
- 2025-06-30 to 2026-06-30 estimated range: [1.34$, 3.08$]
Financial Metrics affecting the ANEB estimates:
- Negative: Non-GAAP EPS, $ of -0.32 <= 0.10
- Negative: Operating cash flow per share per price, % of -12.61 <= 2.35
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -4.88 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
Short-term ANEB quotes
Long-term ANEB plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $6.83MM | $11.78MM | $8.31MM |
| Operating Income | $-6.83MM | $-11.78MM | $-8.31MM |
| Non-Operating Income | $0.01MM | $0.05MM | $0.11MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $2.96MM | $5.60MM | $3.55MM |
| Income(Loss) | $-6.83MM | $-11.73MM | $-8.20MM |
| Profit(Loss) | $-6.83MM | $-11.73MM | $-8.20MM |
| Stockholders Equity | $15.07MM | $10.60MM | $3.81MM |
| Assets | $15.58MM | $11.67MM | $4.07MM |
| Operating Cash Flow | $-5.44MM | $-9.68MM | $-8.09MM |
| Financing Cash Flow | $0.00MM | $6.38MM | $-0.06MM |
| Earnings Per Share* | $-0.29 | $-0.47 | $-0.32 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.